SC
Scancell Holdings plc
SCNLF · OTC
$0.14 +0.00% (+$0.00)
1M +4.29%
Market Cap £108.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 22.96x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
20 /100
Weak Gross margin 94.95%
FCF margin 136.13%
Net margin 260.50%
Quality
4 /100
Poor ROIC 144.56%
Asset turnover 0.20x
ROA 53.15%
Debt
10 /100
High Current ratio 0.77x
Int. coverage -10.86x
Debt/Equity N/A
Stability
37 /100
Moderate Beta 0.74x
Profitable years 0
EPS volatility 108.62%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SCNLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Phillip John L'Huillier
Employees
61
Headquarters
Oxford
Nadcházející události
23 ŘÍJ
Earnings
Upcoming earnings report
04 ÚNO
Earnings
Upcoming earnings report